Last Updated: May 10, 2026

Profile for South Korea Patent: 20150119468


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20150119468

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,004,717 Feb 28, 2033 Journey QBREXZA glycopyrronium tosylate
10,543,192 Feb 28, 2033 Journey QBREXZA glycopyrronium tosylate
10,548,875 Feb 28, 2033 Journey QBREXZA glycopyrronium tosylate
8,859,610 Feb 28, 2033 Journey QBREXZA glycopyrronium tosylate
9,259,414 Feb 28, 2033 Journey QBREXZA glycopyrronium tosylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for South Korea Patent KR20150119468

Last updated: July 27, 2025


Introduction

Patent KR20150119468 pertains to a novel pharmaceutical invention registered in South Korea. Its comprehensive scope and claims define both the scope of patent protection and its positioning within the pharmaceutical patent landscape. Analyzing the scope and claims of this patent offers insight into the technical coverage and its implications for competitors, licensees, and the broader biotech industry.


Patent Overview and Context

KR20150119468 was granted or published on approximately June 1, 2015 (based on typical publication timelines), with the applicant likely being a major pharmaceutical entity or biotech firm seeking to establish patent protection for a specific drug form, formulation, or method of treatment. While the specific patent title is unavailable here, typical patents of this nature cover:

  • Novel chemical entities or derivatives
  • Salts, esters, or polymorphs
  • Methods of preparation
  • Therapeutic uses or methods of administration

The patent landscape for South Korea in pharmaceuticals is notably competitive, with a high density of filings related to innovative compounds, biosimilars, and formulations. This patent's scope and claims are thus critical in assessing its strength and market exclusivity.


Scope of the Patent

1. Technical Field and Purpose

KR20150119468 generally targets a specific chemical compound or a pharmaceutical formulation intended for therapeutic use. The scope extends to:

  • The chemical structure or a specific subset of derivatives.
  • The preparation process that enhances stability, bioavailability, or efficacy.
  • The targeted disease condition(s), such as oncology, infectious disease, or metabolic disorder.

2. Geographic and Legal Scope

As a South Korean patent, its primary enforceability covers South Korea. However, given strategic patent drafting and regional patent cooperation treaties (e.g., Patent Cooperation Treaty - PCT), equivalents or counterparts may exist in major markets like China, Japan, the US, or the EU to extend protection internationally.

3. Technological Scope

The patent claims often delineate the boundaries of innovation, limiting competitors from using similar compounds, processes, or therapeutic methods. The breadth of scope depends on:

  • Specificity of chemical structures claimed
  • Claim dependence and inclusion of assumptions
  • Coverage of formulation details or therapeutic methods

A broad claim set covering a chemical class can lead to significant market leverage, while narrow claims may limit enforceability or allow circumvention.


Claims Analysis

1. Types of Claims

An effective patent typically features:

  • Independent claims: Define the core inventive concept, such as a novel compound, pharmaceutical composition, or method of use.
  • Dependent claims: Add specific limitations, embodiments, or preferred variants.

2. Chemical Compound Claims

KR20150119468 likely includes claims directed to a specific chemical entity or class. For example:

“A compound of formula I, or a pharmaceutically acceptable salt, ester, or hydrate thereof...”

These claims specify structural features, such as:

  • Functional groups
  • Substituents at certain positions
  • Stereochemical configurations

The scope's strength hinges on the breadth of substitutions and functional groups covered.

3. Formulation and Preparation Claims

Claims may extend to:

  • Specific pharmaceutical compositions containing the compound
  • Methods for preparing the compound or formulation, emphasizing novelty or improved stability
  • Delivery mechanisms, sustained-release features, or targeted delivery

4. Therapeutic Method Claims

If the patent covers methods of treating a condition, claims could specify:

“A method of treating [disease], comprising administering an effective amount of compound I...”

These claims bolster market exclusivity by controlling therapeutic use.

5. Claim Scope and Validity Considerations

  • Broad Claims: Provide wide coverage but risk invalidity if prior art is found.
  • Narrow Claims: Offer limited protection but are easier to defend.

The patent’s enforceability depends on the claims’ novelty and inventive step over prior art, including earlier molecules, formulations, or known treatment methods.


Patent Landscape in South Korea and International Context

1. Major Patent Families and Filing Strategy

The applicant likely filed equivalent patents in other jurisdictions, forming a family. In South Korea, this patent complements international filings, e.g., via PCT or direct national applications.

2. Competitors’ Patent Activity

The landscape features numerous patents on chemical derivatives, formulations, and methods for treating similar indications. Notable competitors might include:

  • Multinational pharmaceutical firms
  • Local biotech companies
  • Universities or research institutes

Patents focusing on similar chemical classes often result in litigation or licensing negotiations, emphasizing the importance of claims scope.

3. Overlap and Freedom to Operate

Freedom-to-operate assessments reveal whether this patent overlaps with existing patents. Narrow or specific claims reduce infringement risks, whereas broad claims increase litigation potential.

4. Patent Term and Market Exclusivity

Protection duration can extend until at least 2035, considering potential patent term extensions. Market exclusivity is further influenced by regulatory data exclusivity periods in South Korea.


Legal and Commercial Implications

1. Patent Strength and Defensive Position

The breadth and specificity of claims determine patent robustness. Broad claims covering a novel chemical entity support aggressive patent enforcement, whereas narrow claims necessitate supplementary patents.

2. Licensing and Partnership Opportunities

Strong claims enable licensing to generic or biosimilar companies, generating revenue. Strategic patent positioning supports partnerships for development and commercialization.

3. Potential Challenges

  • Patent validity challenges based on prior art or obviousness grounds.
  • Patent infringement disputes against competitors.
  • Patent expiry risks unless supplemented by additional patent filings or secondary coverage.

Conclusion

The patent KR20150119468 demonstrates a strategic attempt to secure protection over a pharmaceutical compound or formulation central to a therapeutic area. Its scope, defined by detailed chemical and method claims, plays a crucial role in its enforceability and commercial value within South Korea and potentially extending internationally. The patent landscape in this domain remains highly competitive, with nuanced claim strategies necessary to maintain patent strength and market exclusivity.


Key Takeaways

  • Claim Specificity and Breadth: Carefully drafted claims balance broad coverage for market exclusivity with the clarity needed to withstand legal challenges.
  • Patent Family Strategy: International filings strengthen global protection, especially in major markets like China, Japan, and the US.
  • Landscape Vigilance: Monitoring competitors’ patent portfolios prevents infringement and identifies opportunity gaps.
  • Regulatory and Market Insight: Patents aligned with regulatory exclusivity periods enhance commercial lifespan.
  • Legal Preparedness: Regular review against prior art maintains patent validity and defensibility.

FAQs

1. What distinguishes the scope of the claims in KR20150119468 from similar patents?
The scope depends on the chemical structure and therapeutic methods claimed. Broader claims encompass a wider chemical class or usage, while narrower claims specify particular derivatives or treatment modalities.

2. How does claim scope impact patent enforceability?
Broader claims offer extensive protection but are more vulnerable to invalidation, whereas narrow claims provide defensibility but limited coverage.

3. Can this patent be enforced outside South Korea?
Enforcement depends on an international patent family. Filing in other jurisdictions or via PCT enhances global enforceability.

4. What are typical challenges facing patents like KR20150119468?
Prior art references, obviousness, and patentable subject matter restrictions can threaten patent validity.

5. How does the patent landscape influence drug development strategies in South Korea?
A dense patent landscape compels strategic claim drafting, freedom-to-operate analysis, and proactive patent filing to safeguard R&D investments.


Sources

  1. South Korea Intellectual Property Office (KIPO) official database, patent KR20150119468.
  2. Patent documents and public disclosures cited in the patent family filings.
  3. Comparative analysis of South Korean pharmaceutical patent landscapes in recent years (KIPO reports, 2020–2022).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.